|
Dana-Farber/Harvard Cancer Center
|
5P30CA006516-53
|
$11,504,298
|
$115,043
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support (CORE) Grant
|
3P30CA016672-42S5
|
$10,405,362
|
$104,054
|
PISTERS, PETER
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Cancer Center Support Grant
|
2P30CA082103-19
|
$7,954,381
|
$159,088
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Regional Oncology Research Center
|
5P30CA006973-55
|
$7,069,034
|
$70,690
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
5P30CA014089-43
|
$6,268,475
|
$62,685
|
FARNHAM, PEGGY
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Cancer Center Support Grant
|
5P30CA068485-23
|
$5,853,094
|
$58,531
|
PIETENPOL, JENNIFER
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Mayo Comprehensive Cancer Center Grant
|
5P30CA015083-44
|
$5,755,389
|
$57,554
|
DIASIO, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
Case Comprehensive Cancer Center Support Grant
|
2P30CA043703-28
|
$5,637,954
|
$112,759
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA047904-30
|
$5,129,654
|
$102,593
|
FERRIS, ROBERT
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Cancer Center Support Grant
|
5P30CA016058-42
|
$4,798,608
|
$95,972
|
POLLOCK, RAPHAEL
|
OHIO STATE UNIVERSITY
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
2P30CA014520-44
|
$4,590,130
|
$45,901
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
University of Colorado Cancer Center Support Grant
|
5P30CA046934-30
|
$3,853,226
|
$38,532
|
SCHULICK, RICHARD
|
UNIVERSITY OF COLORADO DENVER
|
|
Core Support for Cancer Center
|
3P30CA013330-45S1
|
$3,646,138
|
$36,461
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-12
|
$3,203,119
|
$32,031
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Moffitt Cancer Center Support Grant
|
5P30CA076292-20
|
$2,990,966
|
$29,910
|
SELLERS, THOMAS
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Cancer Center Support Grant P30
|
5P30CA093373-16
|
$2,882,980
|
$86,489
|
LARA, PRIMO
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Comprehensive Cancer Center Program at Fox Chase
|
5P30CA006927-53
|
$2,758,277
|
$27,583
|
FISHER, RICHARD
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
Winship Cancer Institute Cancer Center Support Grant
|
5P30CA138292-10
|
$2,574,000
|
$25,740
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA022453-36
|
$2,562,428
|
$76,873
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
SPORE in Ovarian Cancer
|
1P50CA228991-01
|
$2,492,537
|
$299,104
|
SHIH, IE-MING
|
JOHNS HOPKINS UNIVERSITY
|
|
Cancer Center Support Grant (CCSG)
|
5P30CA086862-18
|
$2,446,023
|
$48,920
|
WEINER, GEORGE
|
UNIVERSITY OF IOWA
|
|
MD Anderson Cancer Center Prostate Cancer SPORE
|
5P50CA140388-08
|
$2,404,000
|
$96,160
|
LOGOTHETIS, CHRISTOPHER
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Cancer Center Support Grant
|
5P30CA062203-21
|
$2,317,496
|
$69,525
|
VAN ETTEN, RICHARD
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
Mayo Clinic Ovarian Cancer SPORE
|
5P50CA136393-09
|
$2,300,000
|
$115,000
|
KAUFMANN, SCOTT
|
MAYO CLINIC ROCHESTER
|
|
Mayo Clinic SPORE in Pancreatic Cancer
|
5P50CA102701-15
|
$2,297,971
|
$91,919
|
PETERSEN, GLORIA
|
MAYO CLINIC ROCHESTER
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
5P30CA134274-11
|
$2,266,216
|
$90,649
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Indiana University Melvin and Bren Simon Cancer Center Support Grant
|
5P30CA082709-19
|
$2,184,000
|
$21,840
|
LOEHRER, PATRICK
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
VCU Massey Cancer Center Support Grant
|
5P30CA016059-37
|
$2,170,000
|
$368,900
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
I-SPY2 +: Evolving the I-SPY 2 TRIAL to include MRI-directed, adaptive sequential treatment to optimize breast cancer outcomes
|
5P01CA210961-02
|
$2,124,555
|
$254,947
|
ESSERMAN, LAURA
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Therapy & Research Center at UTHSCSA
|
5P30CA054174-24
|
$2,093,000
|
$83,720
|
MESA, RUBEN
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
Fred & Pamela Buffett Cancer Center Support Grant
|
5P30CA036727-32
|
$2,075,035
|
$83,001
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Exploiting Redox Metabolism Using Pharmacological Ascorbate for Cancer Therapy
|
1P01CA217797-01A1
|
$1,939,848
|
$174,586
|
CULLEN, JOSEPH
|
UNIVERSITY OF IOWA
|
|
Cancer Center Support Grant (CORE) Renewal
|
5P30CA023168-38
|
$1,860,000
|
$130,200
|
RATLIFF, TIMOTHY
|
PURDUE UNIVERSITY
|
|
U.T. M. D. Anderson Cancer Center SPORE in Ovarian Cancer
|
5P50CA217685-02
|
$1,813,624
|
$362,725
|
BAST, ROBERT
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
SPORE in Breast Cancer
|
3P50CA098131-16S1
|
$1,162,609
|
$290,652
|
PIETENPOL, JENNIFER
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Exosomal Drug Delivery
|
5R44CA221487-02
|
$1,000,000
|
$1,000,000
|
SPENCER, WENDY
|
3P BIOTECHNOLOGIES, INC.
|
|
Impact of Hearing Loss and Tinnitus in Cancer Survivors
|
5R01CA212064-02
|
$965,864
|
$965,864
|
MIASKOWSKI, CHRISTINE
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Novel Bone-Targeting Combination Therapy for Osteosarcoma Phase II
|
5R44CA203166-03
|
$860,229
|
$860,229
|
ZINNEN, SHAWN
|
MBC PHARMA, INC.
|
|
Pharmacogenomics of Microtubule Targeting Agents
|
5R01CA192156-04
|
$842,864
|
$278,145
|
KROETZ, DEANNA
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Targeted Therapy for Non Small Cell Lung Carcinoma: Human Phase 1 safety and dose escalation studies
|
5R44CA162629-03
|
$833,374
|
$208,344
|
SERRERO, GINETTE
|
A AND G PHARMACEUTICAL, INC.
|
|
Mechanisms of non-classical multidrug resistance in cancer
|
ZIA BC 010830
|
$804,110
|
$241,233
|
Gottesman, Michael
|
CCR (NCI)
|
|
Integrated Training in Cancer Model Systems
|
5T32CA009156-43
|
$793,807
|
$79,381
|
DER, CHANNING
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Nanoparticle-based targeted codelivery of siRNA and taxane to treat drug-resistant HER2+ breast cancer
|
4R44CA217534-02
|
$745,151
|
$372,576
|
NGAMCHERDTRAKUL, WORAPOL
|
PDX PHARMACEUTICALS, LLC
|
|
The Evaluation of Novel Therapeutics for Genitourinary Malignancies
|
ZIA SC 010098
|
$638,195
|
$31,910
|
Dahut, William
|
CCR (NCI)
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-11S1
|
$629,550
|
$25,182
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Development of Pirenzepine for CIPN
|
2R42CA213555-02
|
$623,955
|
$623,955
|
MIZISIN, ANDREW
|
WINSANTOR, INC.
|
|
TUMOR SPECIFIC DELIVERY OF VERTICILLIN A OVERCOMES EPIGENETIC SILENCING RESPONSIBLE FOR DRUG RESISTANCE
|
1R01CA227433-01
|
$608,862
|
$182,659
|
GRINSTAFF, MARK
|
BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
ZIA BC 005598
|
$584,807
|
$175,442
|
Gottesman, Michael
|
CCR (NCI)
|
|
(PQ9) The role of Bclw (bcl2l2) in preventing chemotherapy induced neuropathy
|
5R01CA205255-03
|
$577,463
|
$577,463
|
SEGAL, ROSALIND
|
DANA-FARBER CANCER INST
|
|
Analysis of Blood Borne Markers in Hormone Sensitive Metastatic Prostate Cancer
|
5R01CA208254-03
|
$519,293
|
$155,788
|
SWEENEY, CHRISTOPHER
|
DANA-FARBER CANCER INST
|
Total relevant funding to Taxol for this search: $24,488,349
|